Target intelligence / Profile preview

No direct cellular target

Molecular classification
Other
01

Overview

The designation "No direct cellular target" is applied to therapeutic agents that do not achieve their clinical effects by binding to a specific biological macromolecule, such as a receptor, enzyme, or transporter. Instead, these agents operate through fundamental physical or chemical mechanisms. Common examples include antacids that neutralize hydrochloric acid in the stomach via simple acid-base chemistry and osmotic laxatives like polyethylene glycol that increase bowel water content through osmotic pressure (StatPearls, NBK526049; NBK537246). Additionally, this category encompasses chelating agents used to treat heavy metal poisoning by sequestering ions and adsorbents like activated charcoal that physically trap toxins within the gastrointestinal tract (NCBI, PMC3654245). Because these substances do not rely on specific protein-ligand interactions, they are generally not subject to traditional receptor-mediated resistance. However, their use can significantly alter physiological parameters, leading to challenges such as electrolyte disturbances or the impaired absorption of other medications. This classification is essential for distinguishing non-specific chemical interventions from targeted molecular therapies in pharmacological research.

Other names
Non-specific mechanismPhysical-chemical actionNon-molecular targetNon-protein target
02

Mechanism of action

Drugs in this category function through direct chemical reactions, such as the neutralization of gastric acid by basic salts (StatPearls, NBK526049), or through physical processes like the creation of an osmotic gradient to retain water in the intestinal lumen (StatPearls, NBK537246). They may also act by sequestering specific molecules or ions through chelation or adsorption (NCBI, PMC3654245).

03

Biological functions

Acid-base neutralizationOsmotic regulationIon chelationAdsorption
04

Disease associations

Gastroesophageal reflux diseaseConstipationHeavy metal poisoningHyperphosphatemiaHyperkalemia
05

Safety considerations

Electrolyte imbalanceMetabolic alkalosisReduced absorption of co-administered drugsSystemic accumulation of inorganic ions (e.g., aluminum or magnesium)
06

Interacting drugs

Magnesium hydroxide

6 more in the full profile.

07

Biomarkers

Gastric pHSerum electrolyte levelsBlood metal concentrationsSerum phosphate levelsStool consistency

Beyond the preview

Go deeper on No direct cellular target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No direct cellular target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call